Literature DB >> 21316833

COPD exacerbation: mortality prognosis factors in a respiratory care unit.

Myriam Aburto1, Cristóbal Esteban, Francisco Javier Moraza, Urko Aguirre, Mikel Egurrola, Alberto Capelastegui.   

Abstract

OBJECTIVE: The aim of our study was to investigate the mortality predictive factors after a severe exacerbations of COPD admitted to a Spanish respiratory intermediate care unit (IRCU). PATIENTS AND METHODS: Prospective observational 2 years study, where we included all episodes of acute exacerbations of COPD with hypercapnic respiratory failure admitted in an IRCU. We analyzed different sociodemographic, functional and clinical variables including physical activity.
RESULTS: We collected data from 102 consecutive episodes admitted to IRCU (90.1% men). Mean age was 69.4±10.6. The mean APACHE II was 19.6±5.0 and 9.5% presented a failure of other non respiratory organ. Non invasive ventilation was applied in 75.3% of the episodes and this treatment failed in 11.6% of them. The duration of stay in the IRCU was 3.5±2.1 days and 8.0±5.3 days in the hospital. The hospital mortality rate was 6.9%, and another 12.7% after 90 days of discharged. In order to predict hospital mortality, multivariant statistics identified a model with AUC of 0.867, based in 3 variables: the number of previous year admission for COPD exacerbation (p=0,048), the respiratory rate after 2 hours of treatment in the IRCU (p=0.0484) and the severity of the disease established with ADO score (p=0.0241).
CONCLUSIONS: The number of previous year admission for COPD exacerbation, the severity of the disease established with ADO score, the respiratory rate after 2 hours of treatment, allow us to identify what patients with a COPD exacerbation admitted in a IRCU can die during this episode.
Copyright © 2011. Published by Elsevier Espana.

Entities:  

Mesh:

Year:  2011        PMID: 21316833     DOI: 10.1016/j.arbres.2010.10.012

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  9 in total

1.  [Antimicrobial treatment of patients with severe acute exacerbation of COPD].

Authors:  B Klapdor; S Ewig
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-03-22       Impact factor: 0.840

2.  Application of appropriateness criteria for hospitalization in COPD exacerbation.

Authors:  Susana Garcia-Gutierrez; José M Quintana; Irantzu Barrio; Marisa Bare; Nerea Fernandez; Silvia Vidal; Nerea Gonzalez; Iratxe Lafuente; Edurne Arteta; Cristóbal Esteban; Esther Pulido
Journal:  Intern Emerg Med       Date:  2013-03-19       Impact factor: 3.397

3.  Prognostic value of different scoring models in patients with multiple organ dysfunction syndrome associated with acute COPD exacerbation.

Authors:  Kun Xiao; Chao Guo; Longxiang Su; Peng Yan; Xin Li; Lixin Xie
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

4.  Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease.

Authors:  Kristina Andelid; Anders Andersson; Shigemi Yoshihara; Christina Åhrén; Pernilla Jirholt; Ann Ekberg-Jansson; Anders Lindén
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-30

5.  Assessment of some inflammatory biomarkers as predictors of outcome of acute respiratory failure on top of chronic obstructive pulmonary disease and evaluation of the role of bacteria.

Authors:  Hanaa Ahmed Shafiek; Nashwa Hassan Abd-Elwahab; Manal Mohammad Baddour; Mohamed Mabrouk El-Hoffy; Akram Abd-Elmoneim Degady; Yehia Mohamed Khalil
Journal:  ISRN Microbiol       Date:  2012-06-21

Review 6.  Efficacy and safety of inhaler steroids in COPD patients: Systematic review and meta-analysis of randomized placebo-controlled trials.

Authors:  Reza Karbasi-Afshar; Jafar Aslani; Mostafa Ghanei
Journal:  Caspian J Intern Med       Date:  2014

7.  Assisted ventilation in COPD - association between previous hospitalizations and mortality.

Authors:  Anne Pernille Toft-Petersen; Christian Torp-Pedersen; Ulla Møller Weinreich; Bodil Steen Rasmussen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-05-03

Review 8.  Efficacy and safety of conventional long acting β2- agonists: systematic review and meta-analysis.

Authors:  Reza Karbasi-Afshar; Jafar Aslani; Mostafa Ghanei
Journal:  Caspian J Intern Med       Date:  2016

9.  Effects of air pollution on acute exacerbation of chronic obstructive pulmonary disease: a descriptive retrospective study (pol-AECOPD).

Authors:  Jairo A Morantes-Caballero; Hugo Alberto Fajardo Rodriguez
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.